EPIQ DIAGNOSTIC ULTRASOUND SYSTEM
Device Facts
| Record ID | K132304 |
|---|---|
| Device Name | EPIQ DIAGNOSTIC ULTRASOUND SYSTEM |
| Applicant | Philips Ultrasound, Inc. |
| Product Code | IYN · Radiology |
| Decision Date | Aug 21, 2013 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1550 |
| Device Class | Class 2 |
| Attributes | Pediatric, 3rd-Party Reviewed |
Indications for Use
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Device Story
EPIQ Diagnostic Ultrasound System is a general-purpose, software-controlled system for acquiring and displaying ultrasound data. Input: ultrasonic pressure waves generated by piezoelectric transducer arrays. Operation: system circuitry sends electronic pulses to transducers; piezo-electric arrays convert pulses to pressure waves; echoes are processed to detect Doppler shifts or create B-mode images. Output: visual display of anatomical structures and blood flow. Used in clinics, hospitals, and point-of-care by healthcare professionals. Features include PercuNav for image-guided navigation/fusion, and various analysis packages for anatomical measurements. Data stored locally or via network in DICOM/JPEG/AVI formats. Clinicians use output for diagnosis and image-guided procedures. Benefits include non-invasive diagnostic imaging and fluid flow analysis.
Clinical Evidence
No clinical trial was required. Safety and effectiveness were demonstrated through bench testing, including software verification and validation, and compliance with international standards (IEC 60601-1, IEC 60601-1-2, IEC 60601-1-6, IEC 60601-2-37, IEC 62359, ISO 10993).
Technological Characteristics
System console with touch screen, soft keys, and QWERTY keyboard. Supports phased, linear, curved linear, TEE, motorized 3D, and pencil transducers. Connectivity via network, DVR, DVD, and USB. Complies with IEC 60601-1, 60601-1-2, 60601-1-6, 60601-2-37, and 62359. Acoustic output limits: Ispta.3 ≤ 720 mW/cm², MI < 1.9, TI < 6.0. Software-controlled.
Indications for Use
Indicated for Fetal/Obstetric, Gynecological, Intra-operative (Vascular, Cardiac), Abdominal, Pediatric, Small Organ (Breast, Thyroid, Testicle), Cephalic (Adult, Neonatal), Trans-rectal, Trans-vaginal, Musculoskeletal (Conventional and Superficial), Urology, Cardiac (Adult, Pediatric, Fetal, Trans-esophageal), Fetal Echo, Peripheral Vessel, and Vascular (Cerebral) applications in clinics, hospitals, and point-of-care environments.
Regulatory Classification
Identification
An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Predicate Devices
Submission Summary (Full Text)
{0}------------------------------------------------
K132304
# 510(k) Summary of Safety and Effectiveness EPIQ Diagnostic Ultrasound System
This summary of safety and effectiveness information is submitted in accordance with 21CFR §807.92
- 1. Submitter's name, address, telephone number, contact person. Philips Ultrasound, Inc. 22100 Bothell Everett Hwy Bothell, WA 98021-8431
AUG
21 2013
Jessica Stenberg, Regulatory Affairs Specialist Contact person: Email: Jessica. Stenberg@philips.com Tel: (425) 487-7371 Fax: (425) 487-8666
Date prepared: June 27th, 2013
- 2. Name of the device, including the trade or proprietary name if applicable, the common or usual name, and the classification name, if known:
Common/usual name: Diagnostic ultrasound system and transducers Proprietary name: EPIQ Ultrasound System
These devices are classified as follows:
| Classification Name | 21 CFR Section | Product Code |
|------------------------------------------|----------------|--------------|
| Ultrasonic Pulsed Doppler Imaging System | 892.1550 | IYN |
| Ultrasonic Pulsed Echo Imaging System | 892.1560 | IYO |
| Diagnostic Ultrasound Transducer | 892.1570 | ITX |
As stated in 21 CFR, parts 892.1550, 892.1560, 892.1570, and 892.1750 each of these generic types of devices have been classified as Class II.
# 3. Substantially Equivalent Devices
Philips Ultrasound believes the EPIQ Ultrasound System is substantially equivalent to the following currently marketed devices:
| Product | 510(k) |
|-------------------------------------------|------------------------------------------------|
| Philips iU22 Diagnostic Ultrasound System | K130499, K121498, K093563, K042540,<br>K030455 |
{1}------------------------------------------------
# 4. Device Description
The EPIQ Diagnostic Ultrasound System is a general purpose, software controlled, diagnostic ultrasound system. Its function is to acquire ultrasound data and to display the data in various modes of operation.
The device consists of two parts: the system console and the transducers. The system console contains the user interface, a display, system electronics and optional peripherals (ECG, printers). In addition to the physical knobs and buttons of the main control panel, the user interface consists of a touch screen with soft key controls, and a QWERTY keyboard.
The removable transducers are connected to the system using a standard technology, multi-pin connectors. The EPIQ system uses standard transducer technology, and supports phased, linear, curved linear array, TEE, motorized 3D curved linear arrays as well as non-imaging (pencil) probes.
Clinical data storage consists of a local repository as well as off-line image storage via the network, DVR, DVD, and USB storage devices. The images are stored in industrystandard formats (Ex: JPEG, AVI, DICOM) and are intended to be readable using industry-standard hardware and software. On-line review of the images is available. Secure access tools are provided to restrict and log access to the clinical data repository according to HIPAA.
The system circuitry generates an electronic voltage pulse, which is transmitted to the transducer. In the transducer, a piezo electric array converts the electronic pulse into an ultrasonic pressure wave. When coupled to the body, the pressure wave transmits through body tissues. The Doppler functions of the system process the Doppler shift frequencies from the echoes of moving targets such as blood to detect and graphically display the Doppler shifts of these tissues as flow.
The EPIQ system gives the operator the ability to measure anatomical structures and offers analysis packages that provide information used by competent healthcare professionals to make a diagnosis. The EPIQ system enables image guided navigation and image fusion via the optional PercuNav feature
## 5. Technological Comparison to Predicate Devices
The EPIQ system is based on the latest technology in circuitry, memory, and essential hardware. While this hardware is new, the intended use and indications for use of the device remain unchanged from the Predicate iU22 system (K130499, K121498, K093563, K042540, K030455).
{2}------------------------------------------------
Both the EPIQ system and the predicate iU22 use both hard and soft keys for operating controls. On the EPIQ system hard keys (knobs, buttons) have been changed to soft keys.
The EPIQ system offers a suite of transducers which have essentialy the same hardware save the connector. The EPIQ system has a new multipin connector which is compact as in comparison to the iU22 transducer connectors. The transducers represent the only patient contact materials of the Ultrasound System. The EPIQ system introduces no new patient contact materials that have not been previously cleared on the predicate iU22 system.
The EPIQ system is a Track 3 system that employs the same fundamental scientific technology as the predicate iU22 system.
# 6. Indications for Use
Abdominal, Cardiac Adult, Cardiac other (Fetal), Cardiac Pediatric, Cerebral Vascular, Cephalic (Adult), Cephalic (Neonatal), Fetabl/Obstetric, Gynecological, Intraoperative (Vascular), Intraoperative (Cardiac), Musculoskeletal (Conventional), Musculoskeletal (Superficial), Other: Urology, Pediatric, Peripheral Vessel, Small Organ (Breast, Thyroid, Testicle), Transesophageal (Cardiac), Transrectal, Transvaginal.
The clinical environments where the EPIQ Diagnostic Ultrasound System can be used include Clinics, Hospitals, and clinical point-of-care for diagnosis of patients.
# 7. Safety Considerations
As a track 3 ultrasound device the EPIQ Ultrasound System is designed to comply with the acoustic output display requirements of IEC 60601-2-37 Ed 2.0 (Particular requirements for the basic safety and essential performance of ultrasonic medical and monitoring equipment) and IEC 62359, Ed 2.0 (Ultrasonics - Field characterization - Test methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields).
The EPIQ Ultrasound System complies with the referenced standard as well as the FDA ultrasound specific guidance for Industry and FDA Staff - Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers (September 9, 2008).
The system acoustic output limits are:
- Ispta.3 ≤ 720 MW/cm² .
- . MI < 1.9
- . 11 < 6.0
The system and transducers are compliant to:
{3}------------------------------------------------
- . IEC 60601-1: Medical electrical equipment. General requirements for basic safety and essential performance, 2005, Amendment 1, 2012
- · IEC 60601-1-2 Medical Electrical Equipment Part 1-2, General Requirements for Basic Safety and Essential Performance – Collateral Standard Electromagnetic Compatibility, 2007
- · IEC 60601-1-6 Medical Electrical Equipment Part 1-6, General Requirements for Basic Safety and Essential Performance – Usability, 2010
- · IEC 60601-2-37: Medical electrical equipment. Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment, 2007
- · IEC 62359, Ultrasonics Field characterization Test methods for the determination of thermal and mechanical indices related to medical diagnostic ultrasonic fields, 2010
# 8. Nonclinical Performance Data
Philips Ultrasound performed the following testing to ensure the safety and effectiveness of the EPIQ device:
- . Software Verification and Validation
- . Non-Clinical Performance Data
- . Non-Clinical Tests
- . IEC 60601-1: Medical electrical equipment. General requirements for basic safety and essential performance, 2005, Amendment 1, 2012
- . IEC 60601-1-2 Medical Electrical Equipment – Part 1-2, General Requirements for Basic Safety and Essential Performance – Collateral Standard Electromagnetic Compatibility, 2007
- . IEC 60601-1-6 Medical Electrical Equipment - Part 1-6, General Requirements for Basic Safety and Essential Performance - Usability, 2010
- . IEC 60601-2-37: Medical electrical equipment. Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment, 2007
- ISO 10993: Biological evaluation of medical devices. .
- . Quality assurance measures applied to the system design and development include, but were not limited to:
- . Risk Analysis
- . Product Specifications
- Design Reviews ●
- . Verification and Validation
{4}------------------------------------------------
# 9. Clinical Data
A clinical trial was not required to demonstrate safety and effectiveness of the EPIQ Diagnostic Ultrasound System. Clinical validation is unnecessary as EPIQ introduces no new indications for use, no new modes or features that have not been previously cleared on the identified predicates. The clinical safety and effectiveness of ultrasound systems with these characteristics are historically accepted for both predicate and subject devices.
# 10. Conclusion
The EPIQ Ultrasound System and transducers is substantially equivalent in safety and effectiveness to the predicate devices identified above:
- . The predicate devices and EPIQ are indicated for the diagnostic ultrasonic imaging and fluid flow analysis.
- . The predicate devices and EPIQ have the same gray-scale and Doppler capabilities.
- . The predicate devices and EPIQ use essentially the same technologies for imaging, Doppler functions and signal processing.
- . The predicate devices and EPIQ have acoustic output levels within the Track 3 FDA limits.
- The predicate devices and EPIQ are manufactured under equivalent quality . systems.
- . The predicate devices and EPIQ are manufactured of materials with equivalent bio safety. The materials have been evaluated and found to be safe for this application.
- . The predicate devices and EPIQ are designed and manufactured to the same electrical and physical safety standards.
# 514 Performance Standards
There are no Sec. 514 performance standards for this device.
## Prescription Status
This is a prescription device. The prescription device statement appears in the labeling.
## Sterilization Sites
Not applicable. No components supplied sterile.
Track This is a Track 3 system
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol resembling an eagle or bird in flight, composed of three curved lines. The symbol is positioned to the right of the text.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 21, 2013
PHILIPS ULTRASOUND, INC. C/O MARK JOB REVIEWER REGULATORY TECHNOLOGY SERVICES LLC 1394 25TH STREET NW BUFFALO MN 55313
Re: K132304
Trade/Device Name: EPIQ Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: July 23, 2013 Received: July 29, 2013
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
This determination of substantial equivalence applies to the following transducers intended for use with the Philips EPIO Diagnostic Ultrasound System. as described in your premarket notification:
| | Transducer Model Number | |
|----------|-------------------------|-------|
| C5-1 | C8-5 | C9-2 |
| C10-3v | C10-4ec | D2cwc |
| D2tcd | D5cwc | L12-3 |
| L12-5 50 | L15-7io | L18-5 |
| S5-1 | S7-3t | S8-3 |
| S12-4 | V6-2 | X5-1 |
| X6-1 | X7-2t | |
{6}------------------------------------------------
Page 2-Mr. Job
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/dcfault.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincercly yours.
Smh.7)
for
Janine Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
{7}------------------------------------------------
#### Indications for Use
K132304 510(k) Number (if known):
Device Name: Philips EPIQ Diagnostic Ultrasound System
Indications for Use:
Fetal/Obstetric Gynecological Intra-operative (Vascular, Cardiac) Abdominal Pediatric Small Organ (Breast, Thyroid, Testicle) Cephalic (Adult, Neonatal) Trans-rectal Trans-vaginal Musculoskeletal (Conventional and Superficial) Urology Cardiac (Adult, Pediatric, Fetal, Trans-esophageal) Fetal Echo Peripheral Vessel Vascular (Cerebral)
The clinical environments where the EPIQ Diagnostic Ultrasound System can be used include Clinics, Hospitals, and clinical point-of-care for diagnosis of patients.
Prescription Use __ X_ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use ____ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OlR)
Michael D. O'Hara
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) K132304
Page 11 of 121
{8}------------------------------------------------
:10(k) No: ***_***
System: EPIQ Ultrasound System
510(k) No: ___________________________________________________________________________________________________________________________________________________________________ Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | | | Mode of Operation {*includes simultaneous B-mode} | | | | | |
|-------------------------------------------|--------------------------------------------|-----|---------------------------------------------------|-------|------|----------|---------------|----------------------------------------|
| General | Specific | B | M | PWD | CWD | Calor | Combined | Other |
| (Track I only) | (Tracks & III) | | | | | Doppler* | (Spec.) | (Spec.) |
| Ophthalmic | Ophthalmic | | | | | | | |
| | Fetal / OB | N | N | ત્ત્વ | | N | Note: 1,2,3 | Note: 5,6,7,8,9,10,12,13,17 |
| | Abdominal | ನ | N | ಗ | | N | Note: 1,2,3 | Note: 5,6,<br>8,9,10,11,12,13,15,16,17 |
| | Intra-operative (Cardiac) | ત્ત | N | N | N | ನ | Note: 1,2,3 | Note: 5,8,9,10,11,12,13 |
| | Intra-operative (Vascular) | N | N | ત્વ | | ನ | Note: 1,2,3 | Note: 5,8,9,10,11,12.13 |
| Fetal Imaging | Laparoscopic | | | | | | | |
| & Other | Pediatric | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 |
| | Small Organ (breast, thyroid,<br>testicle) | ત | N | N | | N | Note: 1,2,3 | Note:<br>5,6,8,9,10,11.12,13,15,17 |
| | Neonatal Cephalic | N | N | N | | N | Note: 1,2,3 | Note: 5,8,9,10,11,12,13,17 |
| | Adult Cephalic | N | గ్ | N | | N | Note: 1,2,3 | Note: 8,9,10,11,12,13,17 |
| | Trans-rectal | N | N | ડી | | N | Note: 1,2,3 | Note:<br>5,6,8,9,10,11,12,13,15,17 |
| | Trans-vaginal | N | ನ | ಷ | | N | Note: 1.2,3 | Note:<br>5,6,7,8,9,10,11,12,13,15,17 |
| | Trans-urethral | | | | | | | |
| | Trans-esoph, (non-Cardiac) | | | | | | | |
| | Musculo-skel. (Conventional) | N | ನ | ನ | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 |
| | Musculo-skel. (Superficial) | N | ನ | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 |
| | Intra-luminal | | | | | | | |
| | Other: GYN | N | N | N | | N | Note: 1,2,3 | Note:<br>5,6,7,8,9,10,11,12,13,15,17 |
| | Other: Urology | N | N | N | | N | Note: 1,2,3 | Note:<br>5,6,8,9,10,11,12,13,15,17 |
| Cardiac | Cardiac Adult | ಷ | N | ನಿ | N | N | Note: 1,2,3,4 | Note: 10,11,12,13,14 |
| | Cardiac Pediatric | ਨ | N | ನ | ત્વ | N | Note: 1,2,3,4 | Note: 10,11,12,13,14 |
| | Trans-esophageal (Cardiac) | ನ | N | ನ | ાર્ત | N | Note: 1,2,3,4 | Note: 10,11,12,13,14 |
| | Other (Fetal Echo) | ਘ | N | ਪ | N | N | Note: 1,2,3,4 | Note: 5,6,8,10,12,13,14 |
| Peripheral | Peripheral vessel | N | N | N | N | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 |
| Vessel | Cerebral vascular | હિ | N | N | N | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 |
| N= new indication<br>Additional Comments: | | | | | | | | |
| *Color Doppler includes Color Amplitude Doppler | Note 9: Color Power Angio (CPA) |
|------------------------------------------------------------------------|---------------------------------|
| Note 1: Combined modes include: B+PWD; B+Color; B+Amplitude;<br>B+M | Note 10: Harmonic Imaging |
| Note 2: Combined modes include: B+M+Color | Note 11: Contrast Imaging |
| Note 3: Combined modes include: B+Color+PWD;<br>B+Amplitude+PWD | Note 12: 3D/4D Imaging |
| Note 4: Combined modes include: B+CWD; B+Color+CWD;<br>B+Amplitude+CWD | Note 13: XRES |
| Note 5: SonoCT | Note 14: TDI |
| Note 6: Imaging for guidance of biopsy | Note 15: Elastography |
| Note 7: Infertility monitoring of follicle development | Note 16: ElastPQ (for Liver) |
| Note 8: Panoramic Imaging | Note 17: PercuNav |
:
{9}------------------------------------------------
510(k) No:
| 510(k) No: | | | | | | | | | |
|------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------|---------------------------------------------------|---------------|------------------------------|---------------------------------|-------------------|---------------------------------------------------|-------------------------------------|--|
| System: | EPIQ Ultrasound System | | | | | | | | |
| Transducer: | CS-1 | | | | | | | | |
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | | |
| | | | | | | | | | |
| | Clinical Application | | | | | | Mode of Operation (*includes simultaneous B-mode) | | |
| General<br>(Track I only) | Specific<br>(Tracks I & III) | B | M | PWD | CWD | Color<br>Doppler* | Combined*<br>(Spec.) | Other<br>(Spec.) | |
| Ophthalmic | Ophthalmic | | | | | | | | |
| | Fetal / OB | N | N | N | | N | Note: 1,2,3 | Note: 5,6,7,8,9,10,12,13 | |
| | Abdominal | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,<br>9,10,11,12,13,16,17 | |
| Fetal Imaging<br>& Other | Intra-operative (Cardiac) | | | | | | | | |
| | Intra-operative (Vascular) | | | | | | | | |
| | Laparoscopic | | | | | | | | |
| | Pediatric | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 | |
| | Small Organ (breast, thyroid, testicle) | | | | | | | | |
| | Neonatal Cephalic | | | | | | | | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Cardiac) | | | | | | | | |
| | Musculo-skel. (Conventional) | | | | | | | | |
| | Musculo-skel. (Superficial) | | | | | | | | |
| | Intra-luminal | | | | | | | | |
| | Other: GYN | N | N | N | | N | Note: 1,2,3 | Note: 5,6,7,8, 910,11,12,13,<br>17 | |
| | Other: Urology | N | N | N | | N | Note: 1,2,3 | Note: 5,6,,8, 9,10,11,12,13,<br>17 | |
| Cardiac | Cardiac Adult | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | |
| | Trans-esophageal (Cardiac) | | | | | | | | |
| | Other (Fetal Echo) | N | N | N | | N | Note: 1,2,3 | Note: 5,6,10,12,13 | |
| Peripheral<br>Vessel | Peripheral vessel | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,17 | |
| | Cerebral vascular | | | | | | | | |
| | N= new indication | | | | | | | | |
| | Additional Comments: | | | | | | | | |
| | *Color Doppler includes Color Amplitude Doppler | | | | Note 9: Color Power Angio (CPA) | | | | |
| Note 1: Combined modes include: B+PWD; B+Color; B+Amplitude;<br>B+M | | | | Note 10: Harmonic Imaging | | | | | |
| Note 2: Combined modes include: B+M+Color | | | | Note 11: Contrast Imaging | | | | | |
| Note 3: Combined modes include: B+Color+PWD;<br>B-Amplitude+PWD | | | | Note 12: 3D/4D Imaging | | | | | |
| Note 4: Combined modes include: B+CWD; B+Color+CWD;<br>8-Amplitude+CWD | | | Note 13: XRES | | | | | | |
| Note 5: SonoCT | | | | Note 14: TDI | | | | | |
| Note 6: Imaging for guidance of biopsy | | | | Note 15: Elastography | | | | | |
| Note 7: Infertility monitoring of follicle development | | | | Note 16: ElastPQ (for Liver) | | | | | |
| Note 8: Panoramic Imaging | | | | | Note 17: PercuNav | | | | |
| 510(k) No: | | | | | | | | | |
| System: | EPIQ Ultrasound System | | | | | | | | |
| Transducer: | C8-5 | | | | | | | | |
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | | |
| Clinical Application | | Mode of Operation (*includes simultaneous B-mode) | | | | | | | |
| General<br>(Track I only) | Specific<br>(Tracks I & III) | B | M | PWD | CWD | Color<br>Doppler* | Combined*<br>(Spec.) | Other<br>(Spec.) | |
| Ophthalmic | Ophthalmic | | | | | | | | |
| Fetal Imaging<br>& Other | Fetal / OB | | | | | | | | |
| | Abdominal | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13 | |
| | Intra-operative (Cardiac) | | | | | | | | |
| | Intra-operative (Vascular) | | | | | | | | |
| | Laparoscopic | | | | | | | | |
| | Pediatric | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13 | |
| | Small Organ (breast, thyroid, testicle) | | | | | | | | |
| | Neonatal Cephalic | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,12,13 | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Cardiac) | | | | | | | | |
| | Musculo-skel. (Conventional) | | | | | | | | |
| | Musculo-skel. (Superficial) | | | | | | | | |
| | Intra-luminal | | | | | | | | |
| | Other: GYN | | | | | | | | |
| | Other: Urology | | | | | | | | |
| Cardiac | Cardiac Adult | | | | | | | | |
| | Cardiac Pediatric | | | | | | | | |
| | Trans-esophageal (Cardiac) | | | | | | | | |
| | Other (Fetal Echo) | | | | | | | | |
| Peripheral<br>Vessel | Peripheral vessel | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13 | |
| | Cerebral Vascular | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13 | |
| | N= new indication | | | | | | | | |
| | Additional Comments: | | | | Note 9: Color Power Angio (CPA) | | | | |
| *Color Doppler includes Color Amplitude Doppler<br>Note 1: Combined modes include: B+PWD; B+Color; B+Amplitude;<br>B+M | | | | | Note 10: Harmonic Imaging | | | | |
| Note 2: Combined modes include: B+M+Color<br>Note 3: Combined modes include: B+Color+PWD;<br>B+Amplitude+PWD | | | | | Note 11: Contrast Imaging | | | | |
| Note 4: Combined modes include: B+CWD; B+Color+CWD;<br>B+Amplitude+CWD | | | | | Note 12: 3D/4D Imaging | | | | |
| Note 5: SonoCT | | | | | Note 13: XRES | | | | |
| | Note 6: Imaging for guidance of biopsy | | | | Note 14: TDI | | | | |
| | Note 7: Infertility monitoring of follicle development | | | | Note 15: Elastography | | | | |
| Note 8: Panoramic Imaging | | | | | Note 16: ElastPQ (for Liver) | | | | |
{10}------------------------------------------------
{11}------------------------------------------------
| 510(k) No: | | | | | | | | | |
|------------------------------------------------------------------------|------------------------------------------------------------------------------------|---------------------------------|---------------------------------------------------|-----|---------------------------|---------------------------------|----------------------|------------------------------------------|--|
| System: | EPIQ Ultrasound System | | | | | | | | |
| Transducer: | C9-2 | | | | | | | | |
| Intended Use: | Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | | | | | | | | |
| | Mode of Operation (*includes simultaneous B-mode) | | | | | | | | |
| General | Clinical Application<br>Specific | | | | | Color | Combined * | Other | |
| (Track I only) | (Tracks I & III) | B | M | PWD | CWD | Doppler* | (Spec.) | (Spec.) | |
| Ophthalmic | Ophthalmic | | | | | | | | |
| | Fetal / OB | | | | | | | Note: 5,6,7,8,9,10,12,13,<br>17 | |
| | | N | N | N | | N | Note: 1,2,3 | | |
| | Abdominal | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,<br>17 | |
| | Intra-operative (Cardiac) | | | | | | | | |
| | Intra-operative (Vascular) | | | | | | | | |
| Fetal Imaging | Laparoscopic | | | | | | | | |
| & Other | Pediatric | | | | | | | Note: 5,6,8,9,10,11,12,13,<br>17 | |
| | | N | N | N | | N | Note: 1,2,3 | | |
| | Small Organ (breast, thyroid, | | | | | | | | |
| | testicle) | | | | | | | | |
| | Neonatal Cephalic | | | | | | | | |
| | Adult Cephalic | | | | | | | | |
| | Trans-rectal | | | | | | | | |
| | Trans-vaginal | | | | | | | | |
| | Trans-urethral | | | | | | | | |
| | Trans-esoph. (non-Cardiac) | | | | | | | | |
| | Musculo-skel. (Conventional) | | | | | | | | |
| | Musculo-skel. (Superficial) | | | | | | | | |
| | Intra-luminal | | | | | | | Note: 5,6,8,9,10,11,12,13,<br>17 | |
| | Other: GYN | N | N | N | | N | Note: 1,2,3 | | |
| | Other: Urology | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,<br>17 | |
| | | | | | | | | | |
| | Cardiac Adult | | | | | | | | |
| Cardiac | Cardiac Pediatric | | | | | | | | |
| | Trans-esophageal (Cardiac) | | | | | | | | |
| | Other (Fetal Echo) | N | N | N | | N | Note: 1,2,3 | Note: 5,6,10,12,13 | |
| Peripheral | Peripheral vessel | N | N | N | | N | Note: 1,2,3 | Note: 5,6,8,9,10,11,12,13,<br>17 | |
| Vessel | Cerebral Vascular | | | | | | | | |
| | N= new indication | | | | | | | | |
| | Additional Comments: | | | | | | | | |
| | * Color Doppler includes Color Amplitude Doppler | | | | | Note 9: Color Power Angio (CPA) | | | |
| | Note 1: Combined modes include: B+PWD; B+Color; B+Amplitude; | | | | | Note 10: Harmonic Imaging | | | |
| B+M<br>Note 2: Combined modes include: B+M+Color | | | | | Note 11: Contrast Imaging | | | | |
| Note 3: Combined modes include: B+Color+PWD; | | | | | | | | | |
| B+Amplitude+PWD | |…
